puuma systems, inc
DESCRIPTION
PUUMA Systems, Inc. Innovations in torso support. Existing solutions: Severely Limit passable terrain Create more work for the user to locomote or require massive amounts of power State of the art: Computer controls designed for gait replication - PowerPoint PPT PresentationTRANSCRIPT
PUUMA Systems, Inc
Innovations in torso support
28 March 2001 2
Today’s Torso Support Dilemma
Existing solutions: Severely Limit passable terrain Create more work for the user to locomote or
require massive amounts of power State of the art:
Computer controls designed for gait replication Decrease work through reduced weight
(titanium) Several thousand dollars (but largely covered by
insurance)
28 March 2001 3
Sources of Need Weakness Atrophy Paralysis (total, or partial) Desire for more carrying capacity Amputation (with prosthetic in
place)
28 March 2001 4
Existing Solutions and Shortcomings Knee braces
Locking: bad swing phases; Bad on sloped terrain Non-locking: little to no torso support
((T|)h|)KAFOs Substantial weight; Expensive; Customization;
Only SotA has acceptable swing phase Wheel-chair/cart
Expensive; No stairs*; Special accommodations Walker/arm-brace cane
Stigma; Slow locomotion; Reduced use of hands
28 March 2001 5
Best Practice (Auto-locking knee joint)
SCOKJ (Horton technology)
Free walk (Otto Boch)
28 March 2001 6
On the Horizon (Active locking)
Smart-knee (Horton technology) Replaces mechanical clutch
actuator with sensor triggered solonoids
Sensor walk (Otto Boch) Computer controlled clutch
actuation based on assorted sensors
28 March 2001 7
PUUMA Solutions
Energy conservation: More than compensates for the extra work Leads to a more natural gate More natural feel
Energy dissipation: spring loading and clutch slipping reduce pressure of a locked knee joint allowing for: Faster locomotion Less painful emergency locking
28 March 2001 8
Market Opportunity 100-150k with Post Polio Syndrome over
next 10-20 years ~400k MS/MG/HSP/GBS/MD patients 4m Stroke, 5k ALS, 50k Parkinson’s
patients annually 7m >65 with chronic disability 10m morbidly obese (TBD) debilitating injury and acute
disability (e.g.: partial paralysis; post cast removal)
28 March 2001 9
Market Opportunity:Existing met demand
Sold each year: TBD KAFO’s TBD carts for the obese/weak TBD walker’s
28 March 2001 10
Reasonably Addressable Market
TBD. Likely a large portion of the market for the SCOKJ and FreeWalk plus more people with traditional KAFOs who could see more benefit for their increased cost, plus those who can get by without braces but might choose them if the weight/ unnatural gait were less problematic, particularly the morbidly obese and more post-polio sufferers
28 March 2001 11
The PUUMA Systems Vision
We are going to bridge the gap from KAFO’s being a “only if you can’t walk without them” product to a life aid people, who could do without, may choose to use, be it those who can’t carry the weight of a kafo, or those who wish to carry more weight
28 March 2001 12
PUUMA Applications Anywhere existing quads are
insufficient: Atrophied muscle General weakness Excess load (obesity, body armor,
etc.) Frequent spasm or other regular
sudden loss of quad strength
28 March 2001 13
Customer Benefits A KAFO with a more natural
gait (TBD) A KAFO that carries it’s own
weight and then some…
28 March 2001 14
PUUMA Architecture Three main components:
Joint (knee, hinge, drum) consisting of: Outer Clutch Spring Inner Clutch
Control (microprocessor and interface) Frame (human physical interface)
consisting of Thigh frame Shank frame (optional?) Ankle/heel/foot frame
Potential for using existing infrastructure (Orthotists)
28 March 2001 15
PUUMA Family Just the hinge (for orthotists to build a
KAFO with) Just the knee (hinge in a knee brace,
not a KAFO) Full KAFO* Full double HKAFO* – a backpack mount PUMAX variation(s)
*(not necessarily “orthotic”)
28 March 2001 16
Competing Solutions Existing competitors:
SCOJK/SmartKnee and FreeWalk/Sensor walk
Potential competitors: Durfee/Rivard Pneumatic Stored-Energy, Hybrid
Orthosis Gharooni/Heller/Tokhi Hybrid Spring Brake Orthosis Agrawal/Banala Active Leg Orthisis Hal Bleex Yobotics
28 March 2001 17
Key Differentiators Strong basis in energy conservation
principals not well grasped by others (if the existing research is any guide)
Strong team of engineers Greater applicability to non-medical
uses
28 March 2001 18
Potential Customers Orthotists Direct to the afflicted Rehab centers Military “human mule” operations (brain-fart:
could also be used on pack animals to increase their load capacity)
28 March 2001 19
Risks Potential FDA complications Unforseen patent infringement Orthotist bias against non-orthotists Orthotist minimums to begin offering Failure to secure insurability comparable to
competitor products Personal injury liability Severe sensitivity to staff losses Possibly unrealistic quality control demands
28 March 2001 20
Backup Note: don’t go into the wilderness
over this – a basic plan for the minimum means of cashing in on our work to date
Reduce our development to a focus on just the hinge
Market the hinge alone to Orthotists License to Horton and/or Otto Bock
28 March 2001 21
Engineering <others>
28 March 2001 22
Development Milestones Knee Development Control Development Frame Alpha prototype Clinical trial ready prototype Road show prototype
28 March 2001 23
Drum Development Milestones
M1 - Single spring 100k cycle test (M1a – 4 spring 100k cycle test)
M2 - Inner clutch/single spring 100K M3 – Outer clutch 100k cycle test M4 – Inner clutch/spring/outer spring
100K M5 – Software Testbed
28 March 2001 24
Milestone One Single spring 100k cycle test
-Cam Lifts Weight to apex, weight falls, applies torque to spring.
-Monitor drum angle over 100K cycles
-Make sure spring does not fracture or fatigue
28 March 2001 25
Milestone Two
Inner clutch/single spring 100K 1 2
3 4
-Inner clutch engaged, weight
drops
-Spring compresses, inner clutch latches
-Inner clutch released, weight
goes up
-Monitor drum angle, clutch
engagement angle
28 March 2001 26
Milestone Three
Outer clutch 100k cycle test
1 2
3 4
1
3
-Outer Clutch engaged, weight
drops
-Outer clutch catches,
released, then weight lifts
-Small spring lifts lever for next cycle
-Monitor clutch engagement
angle, test for controlled slippage
28 March 2001 27
Milestone Four
Inner clutch/spring/outer spring 100K
1 2
3 4
-Outer and Inner clutch engaged,
weight drops, spring compresses
-Inner clutch catches at max compression
-Inner clutch releases, spring helps to lift
weight, outer clutch rotates
-Outer clutch released, retaining spring pulls outer clutch in correct
position
-Monitor drum angle, inner clutch
engagement angle, etc
28 March 2001 28
Milestone Five
Software Testbed -Ankle can slide to
simulate a step
-Best representation of
actual walking
-Used to develop software, not to specifically test
components
28 March 2001 29
PUUMA SW Architecture <others>
28 March 2001 30
Financial Assumptions FDA costs will be low Little to no additional IP costs No expensive ingredients At least a year of burn
28 March 2001 31
Cash Flow Income is >1 year away Profitability is significantly beyond
that Salaries R&D COGS
28 March 2001 32
Cash Flow - First Product (TBD)
Do we have a sense yet of the production cost of just the hinge?
Do we have an estimate of time and costs for the aforementioned prototypes and tests?
Do we have a sense of regulatory costs and delays (no—it’s time to consult a pro…)?
28 March 2001 33
Financials (much TBD) We need to forecast our operations
cost, estimate our prototyping costs, and guestimate our cost to produce 10 units
We need to identify our regulatory compliance cost
We need to get clear separation between company vs. Carvey assets
28 March 2001 34
OperationsPhase one Planning/FDA compliancePhase two Final prototyping Testing Funding explorationPhase three Marketing/road show (orthotics conferences) Finalizing shipping product and planning production
28 March 2001 35
Marketing and SalesPhase One Market Size Study Early Customer Identification Strategic relationships Sales and distribution planning Feature Release planningPhase Two Shows, white papers, press releases Marketing Rollout, Sales Kit Strategic relationships/partnerships
28 March 2001 36
General and Administration
Phase one (Next 10 days) Management/roles/responsibilities
Near term deliverables Settling Incorporation/Stock
Separation between company vs. Carvey assets
Ownership behind us: Cannot kick down the road, but maintain
flexibility to resolve inequitabilities Default position we can agree on now, 6
month moratorium Minutia: Bank accounts, filings, identity
(website, contact points, logo, etc.)
28 March 2001 37
General and AdministrationPhase two (next 30 days) Planning Operations: budget, contracts,
legal/regulatory Engineering: frame, control, knee
milestones reviewed, resource listPhase three “Hello world”, marketing, conference
circuit Seeking investment or choosing not to